Systematic review: the pathophysiology and management of polycystic liver disease
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic review: the pathophysiology and management of polycystic liver disease
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 34, Issue 7, Pages 702-713
Publisher
Wiley
Online
2011-07-27
DOI
10.1111/j.1365-2036.2011.04783.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study
- (2011) Vicente E. Torres et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease
- (2011) Maria V. Irazabal et al. KIDNEY INTERNATIONAL
- Isolated Polycystic Liver Disease
- (2010) Qi Qian ADVANCES IN CHRONIC KIDNEY DISEASE
- Treatment Strategies and Clinical Trial Design in ADPKD
- (2010) Vicente E. Torres ADVANCES IN CHRONIC KIDNEY DISEASE
- Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63
- (2010) E Waanders et al. CLINICAL GENETICS
- Reducing Polycystic Liver Volume in ADPKD: Effects of Somatostatin Analogue Octreotide
- (2010) A. Caroli et al. Clinical Journal of the American Society of Nephrology
- Medical and surgical treatment options for polycystic liver disease1
- (2010) Joost P.H. Drenth et al. HEPATOLOGY
- 66 GROWTH OF LIVER VOLUME STOPS AFTER ONE YEAR OF LANREOTIDE IN PATIENTS WITH POLYCYSTIC LIVERS
- (2010) M. Chrispijn et al. JOURNAL OF HEPATOLOGY
- Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease
- (2010) M. C. Hogan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases
- (2010) Loes Van Keimpema et al. LIVER INTERNATIONAL
- Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats
- (2010) C. Renken et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- mTOR Inhibitors in Polycystic Kidney Disease
- (2010) Terry Watnick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
- (2010) Andreas L. Serra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2010) Gerd Walz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening for Intracranial Aneurysm in 355 Patients With Autosomal-Dominant Polycystic Kidney Disease
- (2010) H.W. Xu et al. STROKE
- Cholangiociliopathies: genetics, molecular mechanisms and potential therapies
- (2009) Tatyana Masyuk et al. CURRENT OPINION IN GASTROENTEROLOGY
- Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2009) Loes van Keimpema et al. GASTROENTEROLOGY
- Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice
- (2009) Carlo Spirli et al. HEPATOLOGY
- PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradation
- (2009) Hongyu Gao et al. HUMAN MOLECULAR GENETICS
- Autosomal dominant polycystic kidney disease: the last 3 years
- (2009) Vicente E. Torres et al. KIDNEY INTERNATIONAL
- Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease
- (2009) Esmé Waanders et al. LIVER INTERNATIONAL
- Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease
- (2009) Tevfik Ecder et al. Nature Reviews Nephrology
- Hepatic Cystogenesis Is Associated with Abnormal Expression and Location of Ion Transporters and Water Channels in an Animal Model of Autosomal Recessive Polycystic Kidney Disease
- (2008) Jesús M. Banales et al. AMERICAN JOURNAL OF PATHOLOGY
- Morphological and Functional Features of Hepatic Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease
- (2008) Domenico Alvaro et al. AMERICAN JOURNAL OF PATHOLOGY
- Cholangiocyte primary cilia in liver health and disease
- (2008) Anatoliy I. Masyuk et al. DEVELOPMENTAL DYNAMICS
- The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD)
- (2008) Jesús M. Banales et al. HEPATOLOGY
- 80K-H Interacts with Inositol 1,4,5-Trisphosphate (IP3) Receptors and Regulates IP3-induced Calcium Release Activity
- (2008) Katsuhiro Kawaai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sirolimus Reduces Polycystic Liver Volume in ADPKD Patients
- (2008) Q. Qian et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Disrupted cell adhesion but not proliferation mediates cyst formation in polycystic liver disease
- (2008) Esmé Waanders et al. MODERN PATHOLOGY
- Role of nutrition in liver transplantation for end-stage chronic liver disease
- (2008) Felix Stickel et al. NUTRITION REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search